In the most recent annual U.S. News & World Report Best Hospital Rankings, the nephrology program at NewYork-Presbyterian Hospital earned the #2 ranking in the country and the #1 ranking in New York. The rankings are based on medical outcomes such as survival; patient experience, advanced technology, nurse staffing and more. Patients with complex kidney diseases and urologic conditions can find the full range of treatment options at NewYork-Presbyterian Hospital.
Nephrologists in the Division of Nephrology in the Department of Medicine at NewYork-Presbyterian/Weill Cornell Medical Center work closely with the Departments of Surgery for kidney transplantations. The kidney transplantation program offers pre- and post-transplant counseling for patients and family members, as well as the latest therapies to help reduce the side effects of anti-rejection drugs. Additional renal services include:
- Acute and Chronic Dialysis
- Continuous Renal Replacement Therapy.
Each year the Division handles between 300 and 400 renal consults, 8000 to 9000 hemodialysis procedures, and medical care for 90 to 100 renal transplants. The primary focus of the Division is transplantation immunology and molecular biology. Physicians here examine the mechanisms of action of immunosuppressive drugs used in transplant recipients, tests to guide drug therapy of transplant patients, and treatment strategies to protect the transplanted organ.
At NewYork-Presbyterian/Columbia University Irving Medical Center, clinical services in the Division of Nephrology include transplantation services, acute hemodialysis, and chronic hemodialysis, which is offered in a new state-of-the-art chronic dialysis facility. In addition, every Tuesday morning, the Division hosts The Nephritis Hypertension Clinic, the first specialty clinic of its kind in the United States.
NewYork-Presbyterian is affiliated with the Rogosin Institute. The Rogosin Institute has long been recognized as one of the premier centers for the diagnosis and management of kidney disease in the country, recognized for its unique approach to the prevention, detection, and management of chronic and end-stage kidney disease. Rogosin cares for patients at locations throughout Manhattan, Queens, Brooklyn and the Bronx and operates one of the largest home dialysis programs in New York City. Learn more.